ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 87 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $107,000 | -29.1% | 20,995 | -0.7% | 0.00% | – |
| Q1 2019 | $151,000 | -6.2% | 21,149 | +12.5% | 0.00% | – |
| Q4 2018 | $161,000 | -52.2% | 18,796 | +11.9% | 0.00% | – |
| Q3 2018 | $337,000 | -63.2% | 16,795 | -52.7% | 0.00% | -100.0% |
| Q2 2018 | $917,000 | +43.3% | 35,507 | +32.8% | 0.00% | 0.0% |
| Q1 2018 | $640,000 | -25.5% | 26,743 | +5.6% | 0.00% | 0.0% |
| Q4 2017 | $859,000 | +23.2% | 25,335 | -22.9% | 0.00% | 0.0% |
| Q3 2017 | $697,000 | +152.5% | 32,878 | +95.5% | 0.00% | – |
| Q3 2016 | $276,000 | -48.1% | 16,817 | -52.1% | 0.00% | -100.0% |
| Q2 2016 | $532,000 | -15.8% | 35,116 | -19.6% | 0.00% | 0.0% |
| Q1 2016 | $632,000 | +191.2% | 43,682 | +470.0% | 0.00% | – |
| Q4 2015 | $217,000 | -23.3% | 7,664 | -54.7% | 0.00% | – |
| Q3 2015 | $283,000 | -40.2% | 16,914 | -6.3% | 0.00% | – |
| Q2 2015 | $473,000 | – | 18,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 984,329 | $6,999,000 | 4.03% |
| Broadfin Capital, LLC | 2,469,894 | $17,561,000 | 3.63% |
| Healthcare Value Capital, LLC | 100,000 | $711,000 | 2.74% |
| ARMISTICE CAPITAL, LLC | 2,744,000 | $19,510,000 | 1.07% |
| DELTEC ASSET MANAGEMENT LLC | 536,836 | $3,817,000 | 0.84% |
| SECTORAL ASSET MANAGEMENT INC | 808,924 | $5,751,000 | 0.69% |
| Mosaic Family Wealth, LLC | 91,314 | $649,000 | 0.26% |
| Worth Venture Partners, LLC | 59,740 | $425,000 | 0.24% |
| EMERALD ADVISERS, LLC | 626,247 | $4,453,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 565,319 | $4,019,000 | 0.16% |